Important notice

Meds75+ – information regarding the use for persons aged 75+

Substances A-Z
  • Zo

  • Zolpidemi tartras
    Used as "PSYCHOLEPTICS"
    Class D
    Avoid use in older persons. Sedative. Significant adverse effects include drug addiction, cognitive disporder and risk for traffic accidents. Increases risk for falls. Non-pharmacological treatments are primary in the treatment of insomnia.
  • Zopiclonum
    Used as "PSYCHOLEPTICS"
    Class C
    Suitable for older persons, with specific cautions. Sedative. For short-term use only. Significant adverse effects include drug addiction, cognitive disporder and risk for traffic accidents. Increases risk for falls. May cause metallic taste in the mouth. Paradoxically, may increase anxiety, restlessness and aggression. Non-pharmacological treatments are primary in the treatment of insomnia.

Icon explanation

Class A A (green): Suitable for the older persons. The medicinal substance can be used as in younger patients. Changes due to aging do not affect the dose or frequency of administration, and the adverse reaction profile is not different from that of younger patients.

Class B B (grey): There is little research evidence, practical experience or efficacy in older persons.

Class C C (yellow): Suitable for older persons, with specific cautions. The medicinal substance can be used by older persons, but the dose might either have to be reduced, or the frequency of administration decreased due to mild or moderate renal insufficiency or a significant risk of interactions or adverse reactions.

Class D D (red): Avoid use in older persons. Use is possible only in exceptional cases or on a one-off basis. Changes due to aging predispose older persons to adverse or dangerous reactions to the drug. The risk of adverse reactions typically exceeds the benefits.

Meds75+ data source is Finnish Medicines Agency Fimea (licensed under CC BY 4.0).
Data updated on Mar 30, 2021.